Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription 13.07.2026 1 Adv Biomed Res 1 Am J Epidemiol 1 Am J Obstet Gynecol 1 APMIS 1 Biochem Pharmacol 1 Biofactors 1 Biostatistics 2 BMC Cancer 1 BMC Public Health 1 BMJ Open 1 BMJ Open Qual 1 Br J Hosp Med (Lond) 1 Brachytherapy 1 Cancer 1 Cancer Control 1 Cell Oncol (Dordr) 1 Chem Biodivers 1 Chin Med J (Engl) 1 Clin Case Rep 1 Comput Biol Chem 1 Ecancermedicalscience 1 Front Med (Lausanne) 2 Front Oncol 1 Gynecol Obstet Fertil Senol 1 Health Promot J Austr 2 Hum Vaccin Immunother 2 Infect Agent Cancer 2 Int J Gynecol Cancer 1 Ir J Med Sci 1 J Am Dent Assoc 3 J Gynecol Oncol 1 J Radiat Res 1 J Vasc Interv Radiol 1 J Vis Exp 1 J Womens Health (Larchmt) 1 JAMA Netw Open 1 JAMA Surg 1 JCO Glob Oncol 1 Med Clin (Barc) 1 MedComm (2020) 2 Microbiol Spectr 1 NEJM Catal Innov Care Deliv 2 PLoS One 1 Pol J Pathol 1 Pract Radiat Oncol 3 Sci Rep 1 Surg Oncol 1 Toxicol Lett 1 Urologiia 1 World J Surg Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Adv Biomed Res

1. AJORLOO M, Alamdary A, Samaie S, Arabi Mianroodi R, et al
   Oncolytic Effects of S89K Matrix Protein of Vesicular Stomatitis Virus in Cervical Cancer.
   Adv Biomed Res. 2026;15:28.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

2. KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
   Measuring the Validity of Survey Questions on Breast, Cervical, Colorectal, and Lung Cancer Screening.
   Am J Epidemiol. 2026 Feb 27:kwag040. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

3. CUSIMANO MC, Poxon A, Gien LT, Sutradhar R, et al
   Association of Surgical Approach with Oncologic Outcomes in Low-Risk Cervical Cancer.
   Am J Obstet Gynecol. 2026 Jul 4:S0002-9378(26)00348.
   PubMed         Abstract available
   
   

   
   APMIS

4. DIAZ DEL ARCO C, Aguilera Hervas M, Ramirez Mena M, Garcia Martinez R, et al
   High-Risk Human Papillomavirus Prevalence and Genotype Distribution in Two Opportunistic Cervical Screening Periods in Spain: A Tertiary Hospital-Based Study.
   APMIS. 2026;134:e70234.
   PubMed         Abstract available
   
   

   
   Biochem Pharmacol

5. LIU X, Yang Y, Zhang B, Gao X, et al
   Flubendazole inhibits cervical carcinoma by targeting DHODH to induce ferroptosis and mitophagy.
   Biochem Pharmacol. 2025;242.
   PubMed         Abstract available
   
   

   
   Biofactors

6. LIU M, Zhang L, Fan Y, Han L, et al
   HPV Infection Drives CXCL8(+) Neutrophil-Mediated Immune Suppression in Cervical Cancer.
   Biofactors. 2026;52:e70131.
   PubMed         Abstract available
   
   

   
   Biostatistics

7. MAO F, Campos NG, Cheung LC
   Data-augmented multistate modeling for chronic disease processes using cross-sectional studies: application to HPV and cervical precancer.
   Biostatistics. 2026;27:kxag022.
   PubMed         Abstract available
   
   

   
   BMC Cancer

8. MENG H, Tan L, Chen Y, Wang D, et al
   Phosphoinositide metabolism-related prognostic genes and their prognostic value in cervical cancer: an investigation based on transcriptome, single-cell analyses and verification.
   BMC Cancer. 2026 Jul 9. doi: 10.1186/s12885-026-16509.
   PubMed         Abstract available
   
   
9. NOGUERAS-GONZALEZ GM, Inam ME, Msadabwe S, Lee KL, et al
   Impact of social determinants of health on cervical cancer stage at presentation among women in Zambia: a cross-sectional single-center epidemiological study.
   BMC Cancer. 2026 Jul 9. doi: 10.1186/s12885-026-16315.
   PubMed         Abstract available
   
   

   
   BMC Public Health

10. BARTHOLOMEW K, Yang LPH, Neville C, Maxwell A, et al
    An implementation study of text invitation, mailed at-home human papillomavirus (HPV) self-testing and telehealth management in Aotearoa New Zealand, with a nested randomised controlled trial that compared offering an incentive vs. no offer with a rep
    BMC Public Health. 2026;26:2108.
    PubMed         Abstract available
    
    

    
    BMJ Open

11. LANYO GS, Nabe B, Tutu AO, Asore MA, et al
    Determinants of cervical screening in Ghana: a systematic review.
    BMJ Open. 2026;16:e111770.
    PubMed         Abstract available
    
    

    
    BMJ Open Qual

12. BONALA SR, Subramanian BV, Venati C, Selvamary H, et al
    Improving compliance with curative radiotherapy for cervical cancer in a high-volume centre in India: a bundled workflow (AID-CARE) quality improvement project.
    BMJ Open Qual. 2026;15:e003874.
    PubMed         Abstract available
    
    

    
    Br J Hosp Med (Lond)

13. XU K, Zhang G
    Diagnostic Value of SCC-Ag Combined With CYFRA 21-1 in Predicting Long-Term Lymph Node Metastasis After Cervical Cancer Surgery.
    Br J Hosp Med (Lond). 2026;87:55133.
    PubMed         Abstract available
    
    

    
    Brachytherapy

14. CHAVIS YC, Jin R, Leach DF 3rd, Walker KV, et al
    Addressing barriers to care: A proposed model to predict prolonged treatment time among patients with locally advanced cervical cancer.
    Brachytherapy. 2026 Jul 4:S1538-4721(26)00082.
    PubMed         Abstract available
    
    

    
    Cancer

15. ARENA L, Alizai Q, Elemosho A, Chatzipanagiotou OP, et al
    Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.
    Cancer. 2026;132:e70462.
    PubMed         Abstract available
    
    

    
    Cancer Control

16. REMKES A, Gheit T, Martinez-Perez GZ, Fusco D, et al
    Moving Beyond the Female-Only Paradigm: Arguments for Accelerating the Global Gender-Neutral Human Papillomavirus Vaccination.
    Cancer Control. 2026;33:10732748261466385.
    PubMed         Abstract available
    
    

    
    Cell Oncol (Dordr)

17. STONYTE V, Fjeldbo CS, Langiu M, Joy-Immediato M, et al
    Elevated GCN2 levels in cancer cells confer protection from mitotic stress and faster cell movement.
    Cell Oncol (Dordr). 2026;49:92.
    PubMed         Abstract available
    
    

    
    Chem Biodivers

18. ABADIA ACM, Trujillo Chacon LM, Willig JB, Osorio E, et al
    Comparative Evaluation of the Cytotoxic Effect of Dysphania ambrosioides Extracts Against Human Breast and Cervical Cancer Cells.
    Chem Biodivers. 2026;23:e71452.
    PubMed         Abstract available
    
    

    
    Chin Med J (Engl)

19. LIN X, Zheng J, Li Y, Wang S, et al
    Oncogenic DNMT3B as a therapeutic target for cervical cancer.
    Chin Med J (Engl). 2026 Jul 3. doi: 10.1097/CM9.0000000000004130.
    PubMed         Abstract available
    
    

    
    Clin Case Rep

20. MOURA M, Bras IM, Alves C, Aguiar T, et al
    Acquired Vulvar Lymphangiomatosis: A Rare Condition After Cervical Cancer Treatment.
    Clin Case Rep. 2026;14:e73117.
    PubMed         Abstract available
    
    

    
    Comput Biol Chem

21. LIN X, Xie L, Shao K, Jing J, et al
    Unveiling the identification of the genetic features and biological characteristics shared between cervical cancer and venous thromboembolism.
    Comput Biol Chem. 2026;124.
    PubMed         Abstract available
    
    

    
    Ecancermedicalscience

22. MREMA A, Tarimo Q, Lidenge SJ, Shungu R, et al
    Factors associated with depression among women living with HIV and cervical cancer in Tanzania: a cross-sectional study.
    Ecancermedicalscience. 2026;20:2128.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

23. RONSINI C, Di Nuzzo A, Cucinella G, Solazzo MC, et al
    Parametrial involvement in cervical cancer is associated with systemic inflammatory indices: a retrospective observational study.
    Front Med (Lausanne). 2026;13:1842260.
    PubMed         Abstract available
    
    

    
    Front Oncol

24. ZHANG C, Zheng W, Wang X, Wang Z, et al
    Adjunctive photodynamic therapy improves outcomes and quality of life in condyloma acuminatum after radical cervical cancer surgery.
    Front Oncol. 2026;16:1848211.
    PubMed         Abstract available
    
    
25. JULIAN ON, Velarde I, Advani SJ, Mayadev J, et al
    Past present and future of radiosensitization in cervical cancer.
    Front Oncol. 2026;16:1846581.
    PubMed         Abstract available
    
    

    
    Gynecol Obstet Fertil Senol

26. ZABRIAN C, Vanoost A, Theret P, Mancaux A, et al
    [Long-term oncological outcomes and morbidity and mortality associated with radical hysterectomy by laparoscopy versus laparotomy for early-stage cervical cancer].
    Gynecol Obstet Fertil Senol. 2026 Jul 7:S2468-7189(26)00183.
    PubMed         Abstract available
    
    

    
    Health Promot J Austr

27. ANGELO C, Robinson K
    Cervical Cancer Elimination Must Centre Aboriginal and Torres Strait Islander Women.
    Health Promot J Austr. 2026;37:e70214.
    PubMed         Abstract available
    
    

    
    Hum Vaccin Immunother

28. LUO B, Lin Z, Chen J, Wang Y, et al
    Real-world effectiveness of HPV vaccination against high-risk type HPV DNA positivity among adult women aged 18 - 45years in China: A matched test-negative design study.
    Hum Vaccin Immunother. 2026;22:2693440.
    PubMed         Abstract available
    
    
29. RAHIM F, Atasever U
    The population impact of human papillomavirus vaccination on cancer and pre-cancer outcomes: An umbrella review of meta-analyses.
    Hum Vaccin Immunother. 2026;22:2699584.
    PubMed         Abstract available
    
    

    
    Infect Agent Cancer

30. TOMMO TCHOUAKET MC, Gabisa JE, Ngoufack Jagni Semengue E, Moko Fotso LG, et al
    Interoperability of two commercial kits in detecting high oncogenic human papilloma virus and genetic diversity in Cameroon: implications for cervical cancer screening strategies in resource-limited settings.
    Infect Agent Cancer. 2026;21:51.
    PubMed         Abstract available
    
    
31. SHARMA AM, David S, Suresh P, Krishna SS, et al
    Diverse non-vaccine high-risk HPV genotypes in rural Kerala: implications for cervical cancer prevention in an underserved population.
    Infect Agent Cancer. 2026 Jul 8. doi: 10.1186/s13027-026-00778.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

32. NORDQVIST KLEPPE S, Almstedt P, Dillner J, Arroyo Muhr LS, et al
    Design principles and core components of cervical screening registries in the human papillomavirus era: a narrative review and global framework.
    Int J Gynecol Cancer. 2026;36:104751.
    PubMed         Abstract available
    
    
33. LEJEUNE CL, Janovska N, Wakatsuki A, Novak Z, et al
    Analysis of indocyanine green-guided sentinel lymph node mapping for cervical cancer during pregnancy.
    Int J Gynecol Cancer. 2026;36:104810.
    PubMed         Abstract available
    
    

    
    Ir J Med Sci

34. ZHU X, Xiang J, Bai J, Wang L, et al
    Downregulation of miR-3074-5p slows cervical cancer progression by targeting TGFBR2 expression.
    Ir J Med Sci. 2026 Jul 8. doi: 10.1007/s11845-026-04488.
    PubMed         Abstract available
    
    

    
    J Am Dent Assoc

35. FANTOZZI PJ, Sonis ST, Diaz JP, Villa A, et al
    Oral mucositis secondary to datopotamab deruxtecan for advanced-stage cancer managed with cryotherapy after topical steroid failure: A case series study.
    J Am Dent Assoc. 2026;157:787-794.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

36. QU W, Wang H, Jin N, Tang Q, et al
    Comparing paclitaxel and platinum-based concurrent chemoradiotherapy with short-term adjuvant chemotherapy versus platinum-based monotherapy concurrent chemoradiotherapy in patients with postoperative gastric-type endocervical adenocarcinoma with high
    J Gynecol Oncol. 2026;37:e79.
    PubMed         Abstract available
    
    
37. PARK SM, Choi CH, Kim K, Kim H, et al
    Cervical neuroendocrine carcinoma with non-neuroendocrine components has a poorer prognosis than pure neuroendocrine carcinoma.
    J Gynecol Oncol. 2026;37:e80.
    PubMed         Abstract available
    
    
38. ZHOU H, Dai Y, Zhang H, Yang Y, et al
    P16/Ki67 dual staining versus cytology for identifying high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) in triage management of HR-HPV-positive women: a systematic review and meta-analysis.
    J Gynecol Oncol. 2026;37:e68.
    PubMed         Abstract available
    
    

    
    J Radiat Res

39. SUZUKI T, Takahashi R, Tachibana H, Oda S, et al
    Patient stratification for dose scaling in cervical cancer: a model-based analysis using image-guided adaptive brachytherapy.
    J Radiat Res. 2026 Jul 7:rrag047. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Vasc Interv Radiol

40. ZHANG J, Li B, He J, Shu X, et al
    A retrospective study with a 5-year follow-up on the effectiveness of transcatheter arterial chemoembolization for locally advanced cervical cancer.
    J Vasc Interv Radiol. 2026 Jul 9:108945. doi: 10.1016/j.jvir.2026.108945.
    PubMed         Abstract available
    
    

    
    J Vis Exp

41. LI Z, Li M, Tian M, Zhou M, et al
    Efficacy Analysis of Paiteling in Treating Persistent High-Risk Human Papillomavirus after Cervical Cancer Surgery.
    J Vis Exp. 2026;.
    PubMed         Abstract available
    
    

    
    J Womens Health (Larchmt)

42. DIRICAN CD, Jumean S, Dhanesar G, Maroules M, et al
    Cancer Prevention in Women with Sickle Cell Disease: A Scoping Review of HPV Vaccination and Cancer Screening.
    J Womens Health (Larchmt). 2026;35:871-875.
    PubMed         Abstract available
    
    

    
    JAMA Netw Open

43. SHEPPARD AJ, Sutradhar R, Liu N, Kewayosh A, et al
    Population-Level Outcomes for Screening Program Cancers in First Nations People in Ontario, Canada.
    JAMA Netw Open. 2026;9:e2622718.
    PubMed         Abstract available
    
    

    
    JAMA Surg

44. YI H, Liu Y, Yin X, Huang J, et al
    Long-Term Outcomes After Cervical Cold Knife Conization or Loop Electrosurgical Excision Procedure.
    JAMA Surg. 2026;161:737-744.
    PubMed         Abstract available
    
    

    
    JCO Glob Oncol

45. NETHERTON TJ, Aggarwal A, Alakayleh Q, Beadle BM, et al
    Artificial Intelligence-Powered Radiotherapy for Resource-Limited Settings: Advancing Cervical and Prostate Cancer Treatment Planning With the Radiation Planning Assistant.
    JCO Glob Oncol. 2026;12:e2500702.
    PubMed         Abstract available
    
    

    
    Med Clin (Barc)

46. BEIRA SALVADOR PM, Garcia Grandal T, Iglesias Mendez R
    Risk of HSIL/CIN2+ Lesions in Women with Negative Cytology and High-Risk HPV Referred to Colposcopy: Experience in a Population-Based Screening Program.
    Med Clin (Barc). 2026;166:107451.
    PubMed         Abstract available
    
    

    
    MedComm (2020)

47. SHENG Y, Chang Y, Jiang Y, Wang S, et al
    Concurrent Chemoradiotherapy Plus Immunotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer: A Randomized, Single-Center, Phase II Trial of Early Tumor Regression and Pro-Inflammatory Tumor Microenvironment Remodeling.
    MedComm (2020). 2026;7:e70856.
    PubMed         Abstract available
    
    

    
    Microbiol Spectr

48. LIU Y, Qu H, Zhang F, Gan S, et al
    Comparative performance of L1- and E6/E7-targeted HPV genotyping assays based on a unified MeltArray platform.
    Microbiol Spectr. 2026;14:e0020626.
    PubMed         Abstract available
    
    
49. CUI M, Zhang M, Zhang J, Mao R, et al
    Cervicovaginal dysbiosis and microenvironment disruption are associated with cervical carcinogenesis.
    Microbiol Spectr. 2026;14:e0280424.
    PubMed         Abstract available
    
    

    
    NEJM Catal Innov Care Deliv

50. GREEN BB, Mogk J, Crawford-Gallagher B, Beatty TC, et al
    Impact of a Clinic- and Mail-Based Cervical Cancer Human Papillomavirus Self-Collect Screening Program.
    NEJM Catal Innov Care Deliv. 2026;7:CAT250420.
    PubMed         Abstract available
    
    

    
    PLoS One

51. BERZA N, Zodzika J, Kivite-Urtane A, Curkste A, et al
    Factors associated with women's choice for mode of cervical sampling in future cervical cancer screening.
    PLoS One. 2026;21:e0353180.
    PubMed         Abstract available
    
    
52. KIM HJ, Lee HJ, Shin HY, Lee HS, et al
    Understanding barriers and facilitators to cervical cancer prevention among young Korean Women: A focus group interview study.
    PLoS One. 2026;21:e0353242.
    PubMed         Abstract available
    
    

    
    Pol J Pathol

53. TRZESZCZ M, Jach R
    p16/Ki-67 dual-stain immunocytochemistry in precision cervical cancer prevention: immunoprofile and clinical decision-making.
    Pol J Pathol. 2026;77:195-202.
    PubMed         Abstract available
    
    

    
    Pract Radiat Oncol

54. SHOGAN JC, Sukumvanich P, Boisen M, Courtney-Brooks M, et al
    Ovary Sparing Intensity Modulated Radiotherapy Following Ovarian Transposition: A Single Institution Retrospective Dosimetric Analysis of Patients with Cervical Cancer Treated with External Beam Radiation Therapy After Oophoropexy.
    Pract Radiat Oncol. 2026 Jul 6:S1879-8500(26)00195.
    PubMed         Abstract available
    
    

    
    Sci Rep

55. HE M, Huang S, Wang M, Zhu T, et al
    A DLEU2/E2F1 regulatory axis promotes migration and invasion phenotypes in cervical squamous cell carcinoma.
    Sci Rep. 2026;16:20883.
    PubMed         Abstract available
    
    
56. ESSAYAGH T, Essayagh M, Lemriss H, Mourad R, et al
    Prevalence and determinants of human papillomavirus vaccine hesitancy among parents of young girls in Morocco.
    Sci Rep. 2026;16:21387.
    PubMed         Abstract available
    
    
57. AHUJA R, Sharma K, Kumar Tiwari A, Uttam V, et al
    Comparative clinical significance of HPV DNA, HPV E6/E7 mRNA, and p16(INK4a) in cervical cancer among Indian and USA populations: a meta-analysis and systematic review.
    Sci Rep. 2026 Jul 7. doi: 10.1038/s41598-026-59440.
    PubMed         Abstract available
    
    

    
    Surg Oncol

58. SACINTI KG, Sonmezer M
    Surgical radicality and fertility preservation in early cervical cancer: An evolving paradigm.
    Surg Oncol. 2026;67:102474.
    PubMed        
    
    

    
    Toxicol Lett

59. HU Y, Liu X, Zhang Z, Zhou J, et al
    Signaling pathways in tobacco smoking-induced cervical carcinogenesis: Beyond HPV-mediated activation.
    Toxicol Lett. 2026;422:113148.
    PubMed         Abstract available
    
    

    
    Urologiia

60. BERDICHEVSKY B A, Pavlova I V, Berdichevsky V B, Gonyaev A R, et al
    [Clinical digitalization of visual manifestations of late radiation cystitis (pilot study)].
    Urologiia. 2026;:24-29.
    PubMed         Abstract available
    
    

    
    World J Surg Oncol

61. LI JJ, Yang SS, Chen KJ, Jiang LS, et al
    REBACIN((R)) can remove high-risk Human Papillomavirus (HPV) persistent infection efficiently as an effective non-invasive treatment: a multicenter prospective study.
    World J Surg Oncol. 2026;24:283.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum